Drug Delivery Nanosystems in Glioblastoma Multiforme Treatment: Current State of the Art

Glioblastoma multiforme (GBM) is the most common primary malignant Central Nervous System cancer, responsible for about 4% of all deaths associated with neoplasia, characterized as one of the fatal human cancers. Tumor resection does not possess curative character, thereby radio and/or chemotherapy...

Descripción completa

Detalles Bibliográficos
Autores principales: Di Filippo, Leonardo Delello, Duarte, Jonatas Lobato, Luiz, Marcela Tavares, de Araújo, Jennifer Thayanne Cavalcante, Chorilli, Marlus
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Bentham Science Publishers 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8686306/
https://www.ncbi.nlm.nih.gov/pubmed/32867643
http://dx.doi.org/10.2174/1570159X18666200831160627

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8686306/
https://www.ncbi.nlm.nih.gov/pubmed/32867643
http://dx.doi.org/10.2174/1570159X18666200831160627

Ejemplares similares